Tracey provides over 22 years of clinical research experience primarily in oncology, CNS, hematology, organ transplant, and cardiology. Prior to joining InCarda in 2018, Tracey was a Sr. Clinical Operations Consultant supporting Exelixis’ Cabozantinib program for more than 5 years. Prior to that, she was Associate Director of Clinical Operations at XenoPort, and managed clinical trials at Proteolix (Amgen), Novacea, and Cerus. She has worked for both large and small CROs with extensive training and monitoring experience.
Tracey received her Master of Public Administration (MPA) from the University of San Francisco, after graduating from the University of Nebraska-Lincoln with a Bachelor of Science.